MiNK Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.1M | $-2.7M | $-2.6M | $-2.9M | $-4.2M | $-2.8M | $-2.5M | $-1.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $36.1K | $36.1K | $38.6K | $43.7K | $48.8K | $50.8K | $53.9K | $62.6K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $422.2K | $630.4K | $565.8K | $620.6K | $896.6K | $591.1K | $390.0K | $391.3K |
| Net Cash from Operating Activities | $-2.1M | $-1.7M | $-2.1M | $-941.3K | $-1.6M | $-1.3M | $-1.7M | $-3.0M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.4M | $-2.1M | $1.2M | $13.5M | $540 | $576 | $-3 | $6.8K |
| Net Change in Cash | $-718.7K | $-3.8M | $-920.9K | $12.6M | $-1.6M | $-1.3M | $-1.8M | $-3.0M |
| Free Cash Flow | — | — | — | — | — | — | — | — |